Trending Now
Synaptogenix Inc (NASDAQ: SNPX) Announces a Peer-reviewed Paper on Bryostatin
Synaptogenix Inc (NASDAQ: SNPX) announced a peer-reviewed paper published in the Frontiers Aging Neuroscience. The paper came from a collaboration between the company’s Chief...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Sorrento Therapeutics Inc‘s (NASDAQ: SRNE) Subsidiary Scilex Holdings Signs Term Sheet...
Sorrento Therapeutics Inc's (NASDAQ: SRNE) almost 100% owned subsidiary Scilex Holding Company has signed a term sheet to purchase privately-held medical tech firm Ancora...
MAKE IT MODERN
LATEST REVIEWS
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receive Approval From European Commission For Expanded...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has announced that it has received approval from the EU for KALYDECO® granules label extension. The extension includes treatment of...
MAKE IT MODERN
PERFORMANCE TRAINING
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma
Precision BioSciences Inc. (NASDAQ:DTIL) has announced that it has received Fast Track Designation from the FDA for PBCAR269A in treating refractory/relapsed multiple myeloma.
Fast Track...
Mustang Bio Inc. (NASDAQ:MBIO) Enters Agreement With SIRION For LentiBOOST™ Tech And Starts Dosing...
Mustang Bio Inc. (NASDAQ:MBIO) has announced a license agreement with SIRION Biotech GmbH under which Mustang acquired rights to the LentiBOOST™ technology from SIRION....
Journal of Neuroscience Didn’t Find Data Manipulation Evidence in Research Article to Cassava Sciences...
Cassava Sciences Inc. (NASDAQ: SAVA) has received communication from the Journal of Neurosciences that the research article published in July 2021 proposing a new...
Sorento Therapeutics Inc. (NASDAQ:SRNE) Report Encouraging Phase 1B Resiniferatixin (RTX) Study Results In Treating...
Sorento Therapeutics Inc. (NASDAQ:SRNE) has released results of its open-label, multicentre Phase 1b Evaluate Safety and MTD Study of Epidural Resiniferatoxin Injection for treating...
Reason why Enzo Biochem (NYSE:ENZ) surged on Friday
Enzo Biochem, Inc. (NYSE:ENZ) last traded at $2.2500, a gain of $1.0600 (+89.08%). The previous close was at 1.1900, while the open reached...
MAKE IT MODERN
